共 50 条
Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine
被引:15
作者:
Ballou, W. Ripley
[1
]
机构:
[1] GlaxoSmithKline, Worldwide Clin Dev, B-1330 Rixensart, Belgium
关键词:
malaria;
sporozoite;
attenuated;
subunit;
vaccine;
D O I:
10.1016/j.micinf.2007.02.006
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Attenuated pre-erythrocytic stage malaria vaccines protect humans from sporozoite challenge. Current technology limits the feasibility of their commercial scale production and poses a significant risk of contamination with transmissible agents. Overcoming these barriers will be very challenging. In contrast, subunit vaccines appear quite feasible and show great promise as candidate malaria vaccines. (C) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:761 / 766
页数:6
相关论文
共 50 条